Alan Go
Overview
Explore the profile of Alan Go including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
6520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lien I, Moffet H, Liu J, Karter A, Solomon M, Go A, et al.
AJPM Focus
. 2024 Apr;
3(3):100213.
PMID: 38590395
Introduction: The American Heart Association Life's Simple 7 schema can be used to categorize patients' cardiovascular health status as poor, intermediate, or ideal on the basis of smoking, BMI, physical...
2.
Bunning B, Hedlin H, Chen J, Ciolino J, Ferstad J, Fox E, et al.
J Clin Transl Sci
. 2023 Sep;
7(1):e179.
PMID: 37745930
Introduction: Clinical trials provide the "gold standard" evidence for advancing the practice of medicine, even as they evolve to integrate real-world data sources. Modern clinical trials are increasingly incorporating real-world...
3.
Shao B, Afshinnia F, Mathew A, Ronsein G, Thornock C, Irwin A, et al.
J Lipid Res
. 2023 Apr;
64(6):100381.
PMID: 37100172
Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional CVD risk factors cannot completely explain the increased risk. Altered HDL proteome is linked with incident...
4.
Imaizumi T, Fujii N, Hamano T, Yang W, Taguri M, Kansal M, et al.
Kidney Int
. 2023 Feb;
103(5):949-961.
PMID: 36738890
While patients receiving dialysis therapy in the United States are more likely to develop cardiovascular disease (CVD) than those in Japan, direct comparisons of patients with predialysis chronic kidney disease...
5.
Lidgard B, Zelnickv L, Anderson A, Feldman H, Go A, He J, et al.
Kidney360
. 2022 Sep;
3(5):859-871.
PMID: 36128494
Background: Several cardiac biomarkers of cardiac stress, inflammation, and fibrosis (N-terminal pro brain-type natriuretic peptide [NT-proBNP], high-sensitivity troponin T [hsTnT], growth differentiation factor 15 [GDF-15], and soluble ST2 [sST2]) have...
6.
Barrows I, Devalaraja M, Kakkar R, Chen J, Gupta J, Rosas S, et al.
J Am Heart Assoc
. 2022 Sep;
11(18):e025627.
PMID: 36102277
Background Differences in death rate and cardiovascular disease (CVD) between Black and White patients with chronic kidney disease is attributed to sociocultural factors, comorbidities, genetics, and inflammation. Methods and Results...
7.
Lidgard B, Zelnick L, Go A, OBrien K, Bansal N
J Am Heart Assoc
. 2022 May;
11(11):e024913.
PMID: 35621223
Background Contemporary guidelines recommend using atherosclerotic cardiovascular disease screening tools to guide primary prevention. The performance of these scores is not well known in patients with moderate to advanced chronic...
8.
Zelnick L, Shlipak M, Soliman E, Anderson A, Christenson R, Kansal M, et al.
Kidney Int Rep
. 2022 May;
7(4):708-719.
PMID: 35497796
Introduction: Heart failure (HF) is common in chronic kidney disease (CKD); identifying patients with CKD at high risk for HF may guide clinical care. We assessed the prognostic value of...
9.
Jovanovich A, Cai X, Frazier R, Bundy J, He J, Rao P, et al.
J Am Heart Assoc
. 2022 Mar;
11(7):e022891.
PMID: 35322682
Background Deoxycholic acid (DCA) is a secondary bile acid that may promote vascular calcification in experimental settings. Higher DCA levels were associated with prevalent coronary artery calcification (CAC) in a...
10.
Zelnick L, Shlipak M, Soliman E, Anderson A, Christenson R, Lash J, et al.
Clin J Am Soc Nephrol
. 2021 Oct;
16(7):1015-1024.
PMID: 34597264
Background And Objectives: Atrial fibrillation (AF) is common in CKD and associated with poor kidney and cardiovascular outcomes. Prediction models developed using novel methods may be useful to identify patients...